Spots Global Cancer Trial Database for An Italian Experience on Grade 3b Follicular Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An Italian Experience on Grade 3b Follicular Lymphoma
Official Title: An Italian Experience on Grade 3b Follicular Lymphoma
Study ID: NCT02927717
Conditions
Interventions
Study Description
Brief Summary: Study purpose is to evaluate baseline clinical data, outcome after front-line Rituximab containing chemotherapy and survival in patients with grade 3b Follicular Lymphoma. Also an histological central review is planned in order to re-assess baseline diagnosis according to new 2016 World Health Organization (WHO) criteria.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Barbara Botto, MD
Affiliation: AOU Città della Salute e della Scienza di Torino
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
